Principal Scientific Adviser gives an inside view of the emerging vaccine situation in India

"Typically, vaccines and drugs sold in India are sold at prices substantially lower, especially when there is a bulk market. So I would not second guess now. I would wait and see, but I am sure that reasonable pricing will be achieved."

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3xd7vID
via IFTTT

0 comments:

Post a Comment